Author:
Haddad C.,Motulsky E.,Baleine M.
Reference5 articles.
1. Clinical course of hurricane keratopathy;Dua;Br J Ophthalmol,2000
2. Belantamab mafodotin for relapsed or refractory multiple myeloma (dreamm-2): a two-arm, randomised, open-label, phase 2 study;Lonial;Lancet Oncol,2020
3. Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma;Tai;Blood,2014
4. Corneal epithelial findings in patients with multiple myeloma treated with antibody-drug conjugate belantamab mafodotin in the pivotal, randomized, DREAMM-2 study;Farooq;Ophthalmol Ther,2020
5. Ocular adverse events associated with antibody-drug conjugates in human clinical trials;Eaton;J Ocul Pharmacol Ther,2015